Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT06590519

Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM

Led by Universiti Putra Malaysia · Updated on 2024-09-19

160

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Globally, chronic noncommunicable diseases rank as the leading cause of morbidity and mortality. Diabetes is reaching high epidemic proportions across the globe. The prevalence of diabetes is increasing in Saudi Arabia, with diabetes affecting 14.1% of the population across all age groups and 28% of those over the age of 30. Date seed intake is one of the best-studied patterns. Previous studies findinds showed that the phenolic compounds in date seeds have blood sugar-lowering properties. There is a lack of data on how date seed diets may affect glycaemia control and cardiovascular risk among Saudi Arabian patients with T2DM. Therefore, randomised controlled trials (RCTs) will be conducted to assess the effects of date seeds on glycaemic control and cardiovascular risk among diabetes patients.

CONDITIONS

Official Title

Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years old and above.
  • Diagnosis of Type 2 diabetes.
  • Receiving and monitoring diabetes care from diabetes center.
  • Stable HbA1c less than 10% with no hypoglycaemia, hospitalization, or medication changes for at least 6 months.
Not Eligible

You will not qualify if you...

  • Pregnant or lactating women.
  • Diagnosis of cardiac failure or severe renal disease.
  • Physical or mental disability, neurological or cognitive impairment.
  • Severe impairment of vision, hearing, or speech.
  • Known allergy to dates products.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dr Zuriati Ibrahim

Serdang, Selangor, Malaysia, 43400

Actively Recruiting

Loading map...

Research Team

M

Maha Aldaham, Master

CONTACT

Z

Zuriati Ibrahim, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here